Family News

Family News

The Cure JM Foundation produces a monthly newsletter with the latest news and updates about juvenile myositis. Please click below to read past issues of the Family News.

Read the Newsletter

Family News: June 2025

Family News: May 2025

Family News: April 2025

Family News: March 2025

Family News: February 2025

Family News: January 2025

Family News: December 2024

What is IVIG?

What Parents Should Know About IVIg (Intra-Venous ImmunoGlobulin)

The questions about what to do before and post-IVIg to prevent side effects come up often. We know that IVIg can be a very beneficial treatment for JDM, yet it is not without potential side effects. Please read further to minimize the event’s trauma and prevent side effects, e.g., nausea, severe headaches, etc.

What is Juvenile Myositis?

Juvenile myositis, including juvenile dermatomyositis and juvenile polymyositis, is a group of rare and life-threatening autoimmune diseases, in which the body’s immune system attacks its own cells and tissues.

Understanding Second line treatments and side effects

Understanding Second-Line Treatments and Side Effects

Second-line treatments refer to options beyond steroids and methotrexate. They are designed to manage JM while reducing reliance on those medications. We understand that adding new treatments to your child’s regimen can be intimidating. However, rest assured that your doctor has carefully considered the benefits and risks of each option to design the best treatment plan for your family.

Join Cure JM

Membership is free and we’ll connect you with a network of support, encouragement, and resources.

Cure JM supports families, patients, and the juvenile myositis research community.

Interested in DIY fundraising but need help?

We’re here to help!

To have your fundraiser matched, add “DIY Match” in the memo of your online gift or check.